Clinical Trials Browser

Terminated × Esophageal Squamous Cell Carcinoma × apatinib × Clear all

NCT03251417 2023-02-01

Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma

Phase 2 Terminated

Gastrointestinal

Esophageal Squamous Cell Carcinoma